Reata pharmaceuticals stock price
Webb23 feb. 2024 · As of February 24, 2024, Reata Pharmaceuticals Inc’s stock price is $44.51, which is down 11.77% from its previous closing price. At AAII, we stress that investors … Webb8 aug. 2024 · Reata is a clinical-stage biopharmaceutical company that develops novel therapeutics for patients with serious or life-threatening diseases by targeting molecular pathways involved in the...
Reata pharmaceuticals stock price
Did you know?
Webb12 apr. 2024 · The FDA has also not issued any post-approval requirements. Reata has priced Skyclarys at an annual cost of $370,000. ... KalVista Pharmaceuticals’ stock has … Webb13 apr. 2024 · Shares of RETA stock opened at $96.49 on Thursday. Reata Pharmaceuticals has a 1-year low of $18.47 and a 1-year high of $98.52. The company has a market capitalization of $3.54 billion, a price-to-earnings ratio of -11.27 and a beta of 1.52. The stock's fifty day simple moving average is $72.33 and its 200-day simple …
Webb6 apr. 2024 · As of April 6, 2024, the average one-year price target for Reata Pharmaceuticals is $115.97. The forecasts range from a low of $75.75 to a high of … Webb7 mars 2024 · These two healthcare stocks have been swimming against the current.
Webbför 16 timmar sedan · Plus, 3 stocks that are at the top of the list. ... Reata Pharma: SYM: 27.27-0.40-1.45%: Symbotic Inc: Most Popular News. 1. ... Stock Market Overview Market Momentum Market Performance Top 100 Stocks Today's Price Surprises New Highs & Lows Economic Overview Earnings Within 7 Days Earnings & Dividends Stock Screener. WebbRETA has experienced quarterly earnings growth (YOY) of 0, but its quarterly revenue growth (YOY) remains stagnant at -1. Analysts have set a target price of 113.7 for Reata …
WebbReata Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing therapeutics to address serious and life-threatening diseases by ...
Webb17 feb. 2024 · Reata had cash and cash equivalents of $435.9 million at the end of the third quarter of 2024, which is lower than the $590.3 million at the end of 2024. GAAP and Non-GAAP R&D expenses and GAAP... china withholding tax 2020Webb1 apr. 2024 · The last closing price of the REATA PHARMACEUTICALS INC CLASS A share was $93.98 and has changed by 1.39% since the penultimate trading day. The forecast for the further price development, based on current price information, is -0.61% (time horizon: 1 day) and results in a price target of $93.41. china with fish patternWebbReata Pharmaceuticals Inc (NASDAQ:RETA) Reata Pharmaceuticals Inc. Real-Time Quotes. 93.35. BATS BZX Real-Time Price. As of 12:50pm ET. -0.66 / -0.70%. Today’s Change. … grand and toy brandon mbWebbOn average, Wall Street analysts predict that Reata Pharmaceuticals 's share price could reach $115.50 by Mar 27, 2024. The average Reata Pharmaceuticals stock price … grand and toy accountWebbReata Pharmaceuticals (RETA) Stock Key Data. Summary Additional Data Analysts Historical Quotes. ... Consensus Price Target is the stock price analysts expect to see within a period of 0-18 months. china withholding tax rateWebbAt Reata Pharmaceuticals, our mission is to develop innovative therapies that change patients’ lives for the better. Committed to Making a Positive Impact Reata is focused on … china withholding tax softwareWebb13 apr. 2024 · Shares of RETA stock opened at $96.49 on Thursday. Reata Pharmaceuticals has a 1-year low of $18.47 and a 1-year high of $98.52. The company … grand and toy calgary alberta